The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis / Warrender-Sparkes, M; Spelman, T; Izquierdo, G; Trojano, M; Lugaresi, A; Grand'Maison, F; Havrdova, E; Horakova, D; Boz, C; Oreja-Guevara, C; Alroughani, R; Iuliano, G; Duquette, P; Girard, M; Terzi, M; Hupperts, R; Grammond, P; Petersen, T; Fernandez-Bolaños, R; Fiol, M; Pucci, E; Lechner-Scott, J; Verheul, F; Cristiano, E; Van Pesch, V; Petkovska-Boskova, T; Moore, F; Kister, I; Bergamaschi, R; Saladino, Ml; Slee, M; Barnett, M; Amato, Mp; Shaw, C; Shuey, N; Young, C; Gray, O; Kappos, L; Butzkueven, H; Kalincik, T; Jokubaitis, V. - In: MULTIPLE SCLEROSIS. - ISSN 1352-4585. - ELETTRONICO. - (2015), pp. 1-13.

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.

AMATO, MARIA PIA;
2015

Abstract

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.
2015
1
13
Warrender-Sparkes, M; Spelman, T; Izquierdo, G; Trojano, M; Lugaresi, A; Grand'Maison, F; Havrdova, E; Horakova, D; Boz, C; Oreja-Guevara, C; Alrougha...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1006561
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 36
  • ???jsp.display-item.citation.isi??? 30
social impact